| P2093 | author name string | M. E. Kitler | |
| P2860 | cites work | Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine | Q28283221 |
| | Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 |
| | The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials | Q34183760 |
| | Use of check lists in assessing the statistical content of medical studies | Q34284512 |
| | Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial | Q68579824 |
| | Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry | Q68935184 |
| | Confidence intervals for reporting results of clinical trials | Q69584476 |
| | Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial | Q69864810 |
| | A Critique of Methodology in Studies of Anticoagulant Therapy for Acute Myocardial Infarction | Q69864948 |
| | Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60 | Q69886243 |
| | Therapeutic choice in the treatment of hypertension. Initial treatment of newly diagnosed hypertension and secular trends in the prescribing of antihypertensive medications for Medicaid patients | Q69892369 |
| | An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE) | Q69903353 |
| | Assessing Reports of Therapeutic Trials | Q69918345 |
| | The quality of life, research, and care | Q70117143 |
| | How to read clinical journals: V: To distinguish useful from useless or even harmful therapy | Q70152371 |
| | Isolated systolic hypertension in the elderly | Q70180159 |
| | Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia | Q70210293 |
| | Geriatric hypertension therapy: a guide to cost-effectiveness | Q70398640 |
| | The decline in cardiovascular disease mortality | Q71125599 |
| | Randomised trial of treatment of hypertension in elderly patients in primary care | Q34289578 |
| | Symptoms of low blood pressure: a population study | Q35191484 |
| | Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction | Q35704460 |
| | Paradoxical survival of elderly men with high blood pressure | Q35712250 |
| | Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly | Q35713159 |
| | New drugs. Adverse reactions. I. | Q36895450 |
| | Blood pressure and five year survival in the very old | Q36897013 |
| | Choosing the Optimum Therapy for Older Hypertensive Patients | Q36972766 |
| | Clinical trials in the elderly. Pivotal points. | Q37919204 |
| | Adverse drug effects. | Q37919215 |
| | Drug treatment and quality of life in the elderly | Q37919218 |
| | Some problems with antihypertensive drug studies in the context of the new guidelines | Q38145029 |
| | Controlled clinical trials of drug treatment for hypertension. A review | Q38218471 |
| | Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease | Q38218473 |
| | Cost effectiveness in the treatment of hypertension. | Q38241562 |
| | Altered blood pressure homeostasis in advanced age: clinical and research implications | Q38712575 |
| | Adverse effects of antihypertensive therapy | Q38748454 |
| | Assessing the impact of antihypertensive therapy on quality of life in the elderly. | Q38748469 |
| | How far should blood pressure be lowered? | Q39554936 |
| | The changing face of clinical trials | Q39555546 |
| | Future approaches to the treatment of hypertension in the light of results from recent trials | Q39645241 |
| | Should the elderly hypertensive be treated? Evidence from clinical trials | Q39677305 |
| | The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials | Q39750139 |
| | Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension | Q41231614 |
| | Estimating with confidence | Q41870268 |
| | Effects of treatment for isolated systolic hypertension on cognitive status and depression in the elderly | Q41977133 |
| | The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study | Q42200314 |
| | Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations | Q44133679 |
| | The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? | Q44279497 |
| | Vascular dementia due to cardiac arrhythmias and systemic hypotension | Q48222181 |
| | Comparison of three algorithms used to evaluate adverse drug reactions. | Q52633026 |
| | An evaluation of the quality of therapeutic studies in perinatal medicine. | Q52710119 |
| | Randomisation and baseline comparisons in clinical trials. | Q52863961 |
| | Detection and treatment of hypertension in older individuals. | Q54204895 |
| | The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. | Q54319457 |
| | Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels | Q54489341 |
| | The Recent Decline in Ischemic Heart Disease Mortality | Q66937333 |
| | Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group | Q66945018 |
| | How to evaluate drugs. Cost-effectiveness analysis | Q67298357 |
| | How physicians choose drugs | Q68053956 |
| | Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group | Q68277328 |
| | The systolic hypertension in the elderly pilot program: methodological issues | Q68287963 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 86-94 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | Drugs & Aging | Q5308946 |
| P1476 | title | Clinical trials and clinical practice in the elderly. A focus on hypertension | |
| P478 | volume | 2 | |